Home - Products - Others - Other Targets - 3,5-Dihydroxyergosta-7,22-dien-6-one

3,5-Dihydroxyergosta-7,22-dien-6-one

CAS No. 14858-07-2

3,5-Dihydroxyergosta-7,22-dien-6-one( ——— )

Catalog No. M39403 CAS No. 14858-07-2

6-Dehydrocerevisterol is a Steroids product that can be isolated from the fruit body of Ganoderma lucidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    3,5-Dihydroxyergosta-7,22-dien-6-one
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Dehydrocerevisterol is a Steroids product that can be isolated from the fruit body of Ganoderma lucidum.
  • Description
    3β,5α-Dihydroxy-(22E,24R)-ergosta-7,22-dien-6-one exhibits strong or moderate cytotoxic activities against MCF-7, A549, Hela and KB cell lines with IC50 values 4.98 (MCF-7), 1.95 (A549), 0.68(Hela), and 1.50 uM (KB), respectively.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    14858-07-2
  • Formula Weight
    428.65
  • Molecular Formula
    C28H44O3
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PACMA 31

    PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.

  • Adrenomedullin (AM) ...

    Adrenomedullin (AM) (1-52), human (TFA) is an NH2 terminal truncated adrenomedullin analogue,affects cell proliferation and angiogenesis in cancer.

  • GIP (1-30) amide (Hu...

    GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions.